-
-
-
-
-
-
-
Jones Trading Upgrades Korro Bio Inc. (KRRO) to Buy
-
-
-
-
-
-
-
William Blair Reiterates Market Perform Rating on Korro Bio Inc. (KRRO), 'early stages of its pipeline with clinical data unlikely until 2027'
-
-
-
-
-
-
-
Korro Bio (KRRO) Misses Q3 EPS by 192c
-
-
-
-
-
-
-
Cantor Fitzgerald Downgrades Korro Bio Inc. (KRRO) to Neutral
-
-
-
-
-
-
-
Korro Bio Inc. (KRRO) PT Lowered to $147 at Raymond James
-
-
-
-
-
-
-
Cantor Fitzgerald Starts Korro Bio Inc. (KRRO) at Overweight
-
-
-
-
-
-
-
BMO Capital Highlights Favorite Names for 2025 in Biotech
-
483,141 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


